| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y306-03009 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate |
2001-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf84f28a537ea8a2953833a353d6937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8c0e08c2ae283d988d8db52c48fb52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d936c4c0acf608a7040082919f9fc7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6261f30c26feace2b11c07e94bb69a6e |
| publicationDate |
2003-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1298220-A1 |
| titleOfInvention |
Single nucleotide polymorphisms predicting cardiovascular disease |
| abstract |
The present invention relates to an isolated polynucleotide encoding a Na + /K + nATPase polypeptide useful in methods to identify therapeutic agents useful forntreating cardiovascular diseases, the polynucleotide is selected from the groupnconsisting of: n SEQ ID 4 and SEQ ID 5 (baySNP-1765) with allelic variation G in position 240ncontained in a functional surrounding like full length cDNA for Na+/K+ ATPase andnwith or without the Na+/K+ ATPase promotor sequence; and SEQ ID 4 and SEQ IDn5 (baySNP-1765) with allelic variation A in position 240 contained in a functionalnsurrounding like full length cDNA for Na+/K+ ATPase and with or without thenNa+/K+ ATPase promotor sequence. n The invention also provides diagnostic methods and kits including antibodiesndetermining whether a human subject is at risk for a cardiovascular disease. Theninvention provides further polymorphic sequences and other genes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006123885-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008539742-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100754398-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10982281-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2186913-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100851971-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8084198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2386656-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006119905-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005056837-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005056837-A2 |
| priorityDate |
2001-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |